Abstract:The recent epidemic caused by aerosolized SARS-CoV-2 virus illustrates the importance and vulnerability of the mucosal epithelial barrier against infection. Antimicrobial proteins and peptides (AMPs) are key to the epithelial barrier, providing immunity against microbes. In primitive life forms, AMPs protect the integument and the gut against pathogenic microbes. AMPs have also evolved in humans and other mammals to enhance newer, complex innate and adaptive immunity to favor the persistence of commensals over pathogenic microbes. The canonical AMPs are helictical peptides that form lethal pores in microbial membranes. In higher life forms, this type of AMP is exemplified by the defensin family of AMPs. In epithelial tissues, defensins, and calprotectin (complex of S100A8 and S100A9) have evolved to work cooperatively. The mechanisms of action differ. Unlike defensins, calprotectin sequesters essential trace metals from microbes, which inhibits growth. This review focuses on defensins and calprotectin as AMPs that appear to work cooperatively to fortify the epithelial barrier against infection. The antimicrobial spectrum is broad with overlap between the two AMPs. In mice, experimental models highlight the contribution of both AMPs to candidiasis as a fungal infection and periodontitis resulting from bacterial dysbiosis. These AMPs appear to contribute to innate immunity in humans, protecting the commensal microflora and restricting the emergence of pathobionts and pathogens. A striking example in human innate immunity is that elevated serum calprotectin protects against neonatal sepsis. Calprotectin is also remarkable because of functional differences when localized in epithelial and neutrophil cytoplasm or released into the extracellular environment. In the cytoplasm, calprotectin appears to protect against invasive pathogens. Extracellularly, calprotectin can engage pathogen-recognition receptors to activate innate immune and proinflammatory mechanisms. In inflamed epithelial and other tissue spaces, calprotectin, DNA, and histones are released from degranulated neutrophils to form insoluble antimicrobial barriers termed neutrophil extracellular traps. Hence, calprotectin and other AMPs use several strategies to provide microbial control and stimulate innate immunity.

Understanding the Dynamics of Human Defensin Antimicrobial Peptides: Pathogen Resistance and Commensal Induction

[Advances in the Research of Human Defensins].

Recent advances in the research and development of human defensins.

Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases

β-Defensins: Farming the Microbiome for Homeostasis and Health

Human Defensins: Turning Defense into Offense?

ANTIMICROBIAL PEPTIDES: IMPORTANT ROLES IN HUMAN HEALTH AND DISEASES

Defensins in Innate Immunity

Understanding the Roles of Host Defense Peptides in Immune Modulation: From Antimicrobial Action to Potential as Adjuvants

Antimicrobial peptides: Defending the mucosal epithelial barrier

Mechanisms and regulation of defensins in host defense

The Human Anionic Antimicrobial Peptide Dermcidin Induces Proteolytic Defence Mechanisms in Staphylococci.

Combating bacterial infections with host defense peptides: Shifting focus from bacteria to host immunity

173 Human Defensins - Small in Size but Big in Functionality

Defensins: The natural peptide antibiotic

Resistance Mechanisms to Antimicrobial Peptides in Gram-Positive Bacteria

Diversity and Mechanisms of Action of Plant, Animal, and Human Antimicrobial Peptides

Defensins: Transcriptional regulation and function beyond antimicrobial activity

Antimicrobial Peptides (AMPs): New Perspectives on Their Function in Dermatological Diseases

Gram-positive Three-Component Antimicrobial Peptide-Sensing System

Defensins: A Double-Edged Sword in Host Immunity